A NEW point-of-care fingerstick test detects hepatitis B virus (HBV) within one hour, a 2026 diagnostic study has found. The ...
A world-first Australian trial has found that a simple fingerstick test for hepatitis B DNA is as accurate as standard lab testing, paving the way for wider access in remote and resource-limited ...
A world-first Australian trial shows a simple fingerstick test can accurately detect hepatitis B DNA within an hour ...
The Tacoma City Council unanimously approved $30,000 in funding Tuesday to expand access to HIV and sexually transmitted infection (STI) self-testing for LGBTQ+ ...
(MENAFN- IANS) New Delhi, Feb 5 (IANS) A world-first Australian trial has found that a simple fingerstick test for hepatitis B DNA is as accurate as standard lab testing, paving the way for wider ...
In combining the precision of the twiist insulin delivery system with the unmatched longevity of Eversense 365, Sequel and Senseonics are enhancing diabetes management by offering more tools to manage ...
This clearance follows four years of regulatory engagement with the FDA to validate AI-native diagnostics in clinical environments. Athelas Home uses neural-network-based cell analysis and computer ...
Management of gestational diabetes can be more efficient with the use continuous glucose monitoring (CGM), according to new research presented at the Society for Maternal-Fetal Medicine (SMFM) 2026 ...
A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis ...
Credence Research Inc. has released a new study on the Blood Glucose Monitoring Devices Market. According the report the Blood Glucose Monitoring Devices Market is projected to grow from USD 16,202.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results